Skip to main content
. 2022 Oct 13;11(20):6051. doi: 10.3390/jcm11206051

Figure 3.

Figure 3

Adverse events associated with SGLT-2is and proposed preventative measures [36,37,40]. a Occurs only in patients with type 2 diabetes. AKI, acute kidney injury; DKA, diabetic ketoacidosis; eGFR, estimated glomerular filtration rate; HbA1c, glycated hemoglobin; SBP, systolic blood pressure; SGLT-2i, sodium-glucose cotransporter-2 inhibitor; SU, sulfonylurea.